2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $20B | $18B | $16B | $14B | $14B |
Cost of Revenue | $15B | $14B | $13B | $11B | $12B |
Gross Profit | $4.7B | $3.6B | $3.6B | $3.2B | $1.7B |
Gross Profit % | 24% | 21% | 22% | 22% | 12% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$5.4B | -$146M | $736M | -$566M | $91M |
Dep. & Amort. | $2B | $2B | $1.7B | $1.6B | $1.4B |
Def. Tax | -$56M | -$403M | $255M | -$609M | -$416M |
Stock Comp. | $68M | $56M | $101M | $108M | $109M |
Chg. in WC | -$1.6B | -$817M | -$1.1B | -$685M | -$521M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $3.7B | $3B | $2.7B | $1.9B | $1.2B |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $3.7B | $3B | $2.7B | $1.9B | $1.2B |
Receivables | $4.4B | $4.2B | $3.9B | $3.4B | $3.3B |
Inventory | $646M | $727M | $652M | $570M | $0 |
DXC reported strong Q3 FY25 performance, with revenue, adjusted EBIT margin (8.9%, up 140 basis points YoY), and non-GAAP EPS ($0.92, up 7% YoY) exceeding guidance. Free cash flow was $483M for the quarter, surpassing full-year guidance.
Bookings improved significantly, with a book-to-bill ratio of 1.33x, the highest in eight quarters. The pipeline continues to grow, including a higher mix of larger deals in consulting and engineering services.
FY25 guidance was updated: total revenue is expected to decline 4.7%-4.9% organically (better than prior guidance of a 5.5%-4.5% decline), adjusted EBIT margin is raised to 7.5%-8%, and non-GAAP EPS is now expected to be $3.35 (up from $3-$3.25). Free cash flow guidance increased to $625M (from $550M).
Investments in AI capabilities, cloud infrastructure, and IT security are ongoing, with new initiatives like partnerships with SAP and ServiceNow to enhance AI-driven solutions. The company also highlighted successful Gen AI projects with clients like Singapore General Hospital and Ferrari.
Leadership changes and operational improvements are driving better execution, with a focus on profitable growth, improved win rates, and enhanced go-to-market strategies. However, Q4 FY25 revenue is expected to decline sequentially due to weak bookings in the first half of the year.